baber/WOPTO huggingface dataset:
Patent NZ-618159-A (NZ)
Title: Production of a tower
Inventor: KAPITZA JAN
IPC: G01B11/24
Filed: 2012-06-14
Abstract: A method for accurately producing a tower segment of a concrete tower is disclosed. The tower may be used in a wind energy installation. The method consists of the steps: providing a segment mould (2) having at least one formwork (1) for defining a mould of the tower segment that is to be produced and for filling with concrete; filling the segment mould (2) with concrete in order to form the tower segment by the subsequent hardening of the concrete; measuring the tower segment thus hardened for creating a three-dimensional, virtual actual model of said tower segment; producing said three-dimensional actual model; comparing the three-dimensional actual model with a predefined mould, in particular a stored three-dimensional, virtual target model; and determining a deviation between both virtual models and changing the segment mould (2), in particular changing the at least one formwork (1) when the deviation exceeds a first predefined threshold value. A movable shuttering, a contoured tower and fastening anchor are also disclosed.
Patent NZ-623948-A (NZ)
Title: An improved beverage and method of manufacture
Inventor: AIQIAN YE
IPC: A23C21/06
Filed: 2013-12-23
Abstract: Disclosed is an aerated beverage characterised in that the beverage includes a base containing recombined milk and a milk-based retentate.
Patent NZ-624513-A (NZ)
Title: Methods for preparing anti-viral nucleotide analogs
Inventor: COLBY DENISE A
IPC: C07F9/6561
Filed: 2012-10-03
Abstract: Disclosed herein is a method for the selective crystallisation of the diasteromer 9-{ (R)-2-[((S)-{ [(S)-1-(isopropoxycarbonyl)ethyl]amino} phenoxyphosphinyl)methoxy]propyl} adenine (also known as L-alanine, N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl],-1-methylethyl ester) comprising reacting a solvent, and a base with 9-{ (R)-2-[((R,S)-{ [(S)-1-(isopropoxycarbonyl)ethyl]amino} phenoxyphosphinyl)methoxy]propyl} adenine in conditions that provide for the selective crystallization. Also disclosed are methods of preparing intermediates of the compound such as the non-stereospecific precursor 9-{ (R)-2-[((R,S)-{ [(S)-1-(isopropoxycarbonyl)ethyl]amino} phenoxyphosphinyl)methoxy]propyl} adenine.
Patent NZ-626019-A (NZ)
Title: Bracket
Inventor: ANARU HERA MATUI
IPC: A47B96/06
Filed: 2014-06-09
Abstract: A bracket for mounting a feed dispenser, wherein the bracket includes a central portion 212, at least two wings extending from opposite edges of the central portion 212 and perpendicularly away from a first face of the central portion 212, and one or more protrusions 216a, 216b extending perpendicularly away from a second face of the central portion, the or each protrusion further including a substantially downwardly protruding extension, such that at least one of said one or more protrusions extends from one said opposite edge.
Patent NZ-629464-A (NZ)
Title: Dissolvable films and methods of using the same
Inventor: RIELAND ELIZABETH
IPC: B44C1/00
Filed: 2012-11-01
Abstract: The present disclosure provides dissolvable films for customizing art materials, such as inks, paints, and modeling doughs. The invention also provides methods and kits for delivering artistic effects to art materials. The dissolvable films comprise one or more cellulose compounds, propylene glycol, glycerin, and one or more artistic components. The dissolvable film imparts an artistic effect following administration of the film to the art material. In exemplary embodiments, the artistic components of the film comprise one or more colorants which provide a coloring effect. A kit for delivering one or more artistic effects to an art material includes dissolvable films of various colors and shapes, and one or more art materials, such as ink, paint, or modeling dough.
Patent NZ-629944-A (NZ)
Title: Fused azole derivative
Inventor: KUWADA TAKESHI
IPC: C07D491/107
Filed: 2013-03-29
Abstract: Provided is a therapeutic or prophylactic agent for mood disorders, anxiety, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington’s chorea, eating disorders, hypertension, digestive diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune related diseases, depilation, and so on. More specifically, provided is a fused azole derivative represented by general formula (I), which has arginine vasopressin 1b receptor antagonism, or a pharmaceutically acceptable salt thereof.
Patent NZ-701624-A (NZ)
Title: System and method for retro-fitting a shaker
Inventor: POMERLEAU DANIEL GUY
IPC: E21B21/06
Filed: 2010-03-31
Abstract: A vacuum manifold assembly for retrofit connection to a shaker having screen support rails 20 includes a vacuum manifold support frame 6 having a plurality of frame members 6 for engagement with and support by the screen support rails 20 and a vacuum manifold 1a, 1a’ with a fluid conveyance (vacuum) tube 3. The vacuum manifold support frame serves to connect the vacuum manifold beneath the shaker screen 7.
Patent NZ-707331-A (NZ)
Title: Ontology-driven complex event processing
Inventor: TAYLOR KERRY LEA
IPC: G06N5/00
Filed: 2011-09-16
Abstract: Described embodiments relate generally to ontology-driven complex event processing (CEP). When implemented as a computer (105), the computer (105) enables, in communication with a network, user generation and transformation of an event definition into an ontology-based event definition. A computer-implemented transformer component (140) receives the ontology-based event definition, generates event processing instructions and transmits the event processing instructions to a CEP server 150 over the network. The CEP server (150) then observes a plurality of structured messages containing event data and determines whether the event data satisfy all conditions of the event definition and sends an event message responsive to determining that all event definition conditions are satisfied. The described techniques allow an arbitrary high-throughput CEP to be used. A user, unaware of the normally difficult and heterogenous CEP interfaces, can easily construct requests for event alerts using the described interface and a domain ontology that is appropriate for the user’s interest.
Patent NZ-711631-A (NZ)
Title: Density phase separation device
Inventor: BARTFELD BENJAMIN
IPC: G01N1/10
Filed: 2010-05-14
Abstract: A separation assembly (40) for enabling separation of a fluid sample into first and second phases, comprising: a collection container (82) having a first end, a second end, and a sidewall extending therebetween, the collection container defining a longitudinal axis between the first end and the second end; a closure adapted for sealing engagement with the first end of the collection container; and a device comprising a separator having a through-hole (46) defined therethrough, wherein upon applied rotational force to any of the separation assembly, collection container, and separator, the separator transitions from a first position in which the through-hole is in an open position that is not transverse to the longitudinal axis of the collection container for fluid to pass therethrough, to a second position in which the through-hole is in a closed position that is not parallel with the longitudinal axis of the collection container for preventing fluid from being received therethrough, wherein a cannula is spaced apart from the separator during introduction of a specimen into the collection container, wherein the separator includes at least one sealing perimeter, wherein when the separator is in the second position, the at least one sealing perimeter sealingly engages the sidewall of the collection container to prevent fluid from passing between the separator and the sidewall and for preventing fluid from passing through the open through-hole, and wherein at least a portion of the separator is adapted to deform upon application of rotational force.
Patent NZ-712696-A (NZ)
Title: Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
Inventor: LEE CHANGSIK
IPC: C07D413/12
Filed: 2014-04-29
Abstract: The present invention relates to novel urea derivatives and, more particularly, to novel urea derivatives with histone deacetylase (HDAC) inhibitory activity, isomers thereof, pharmaceutically acceptable salts thereof, their use for the preparation of a medicaments comprising the same, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing novel urea derivatives. The novel urea derivatives as selective histone deacetylase (HDAC) inhibitors are effective for the treatment of histone deacetylase-mediated diseases such as malignant tumors, inflammatory diseases, rheumatoid arthritis, neurodegeneration, etc.
Patent NZ-714071-A (NZ)
Title: Tylosin derivatives and method for preparation thereof
Inventor: TOMOYASU HIROSE
IPC: A61K31/7048
Filed: 2014-05-23
Abstract: The present invention relates to new macrolide derivatives, in particular new tylosin derivatives of the formula (Ila), a pharmaceutical or veterinary composition comprising the derivatives; a method for preparation thereof; a method for treating and/or preventing bacterial infections in an animal, wherein the method comprises administering the derivatives or the composition; and a use of the derivatives for the manufacture of medicaments for treating and/or preventing bacterial infections in an animal.
Patent NZ-720201-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: B29C48/395
Filed: 2009-11-13
Abstract: Disclosed is a method of producing sugars using a screw extrusion process, the method comprising: hydrolyzing one or more lignocellulosic materials with cellulase while conveying the one or more lignocellulosic materials through a screw extrusion process, the one or more lignocellulosic materials having been exposed to ionizing radiation; and discharging an extrudate from the screw extrusion process, the extrudate comprising one or more fermentable sugars released from cellulolytic hydrolysis of the one or more lignocellulosic materials.
Patent NZ-727155-A (NZ)
Title: Sodium (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate
Inventor: ZIA VAHID
IPC: A61P31/18
Filed: 2015-06-19
Abstract: The present Invention relates to sodium (2R,5S,13aR)-7,9-dioxo-10 -((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1’,2’:4,5] pyrazino[2,1-b][1,3]oxazepin-8-olate Form I.
Patent NZ-728173-A (NZ)
Title: Urine absorbent pad
Inventor: LUMAQUE-STEEMAN LORNA MATEO
IPC: A61F13/471
Filed: 2015-05-13
Abstract: A disposable urine trap in the form of a foldable pad that envelops the male genitalia and closes around the organ to form a barrier that prevents urine from escaping the trap. The pad includes an asymmetric pair of wings that are separated by a gap and attached to the main body of the pad. The first wing is preferably rectangular in that the distal angles are substantially right angles with parallel side edges and a perpendicular distal edge, and has a length that exceeds a length of a second wing, which is terminates so that the distal edge of the second wing is angled to form an obtuse and an acute angle with respect to its generally parallel sides. Another problem faced by urine traps is that in order to change the said trap, an end user such as a patient would need to be lifted up. As this trap wraps around the male member it mitigates the need for lifting.
Patent NZ-742548-A (NZ)
Title: Melflufen dosage regimens for cancer
Inventor: LINDBERG JAKOB
IPC: A61K31/223
Filed: 2016-12-01
Abstract: The present invention providesmelflufen (melphalan flufenamide; L-Melphalanyl-4- fluoro-L-phenylalanine ethyl ester), or a salt thereof, for use in the treatment or prophylaxis of multiple myeloma, wherein a dosage of melflufen (excluding the mass of any salt) is administered as a parenteral dosage at an infusion rate of 1.0 to 1.8 mg/min. Also provided is melflufen, or a salt thereof, for use in the treatment or prophylaxis of a cancer, for example a solid cancer, wherein a dosage of melflufen is administered as a parenteral dosage at an infusion rate less than 0.8 mg/min (for example 0.3 to 1.0 mg/minor for example 0.3 to 0.8 mg/min).
Patent NZ-745596-A (NZ)
Title: Tetracycline compounds
Inventor: XIAO XIAO-YI
IPC: C07D471/04
Filed: 2013-08-30
Abstract: The widespread use of tetracyclines for therapeutic purposes has led to the emergence of resistance to these antibiotics. Therefore, there is need for new tetracycline analogs with improved antibacterial activities and efficacies against tetracycline responsive diseases or disorders. The present invention relates to the depicted tetracycline compound ((4S,4aS,5aR,12aS)-8-[1-ethyl-pyrrolidin-2-yl]-4-amino-7-methoxy-3, 10, 12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide as a tetracycline antibiotic compound for bacterial infections) as an antibacterial agent.
Patent NZ-745735-A (NZ)
Title: Method for detecting or separating/obtaining circulating tumor cell employing cell proliferation method
Inventor: UMEZU YASUIKI
IPC: G01N33/48
Filed: 2016-03-03
Abstract: The present invention addresses the problem of providing a method for detecting or separating/obtaining a circulating tumor cell (CTC), whereby it becomes possible to reliably and steadily detect or separate/obtain a CTC and a circulating tumor stem cell (CTSC) which are present in trace amounts in a biological circulating body fluid, such as blood and lymph fluid, even under the condition where the type of the tumor cell is not identified yet and the tumor cell is present in a trace amount in the biological circulating body fluid. The problem can be solved by a method for detecting or separating/obtaining a CTC and/or a CTSC in a biological circulating body fluid, said method comprising the following treatment steps (1) to (4): (1) a first step of pretreating a sample collected from the biological circulating body fluid to obtain a mononuclear cell phase, wherein the pretreatment of the sample is the removal of a liquid component and a non-cellular component contained in the biological circulating body fluid; (2) a second step of providing a well plate that is prepared by injecting a liquid culture medium comprising a serum-free culture medium for circulating tumor cell and/or circulating tumor stem cell proliferation use into the well plate, then seeding mononuclear cells obtained in the first step in the well plate, and then incubating the well plate; (3) a third step of removing the liquid culture medium from plate wells obtained by the incubation in the second step; and (4) a fourth step of, subsequent to the third step, detecting or separating/obtaining adherent cells that are adhered onto the plate wells.
Patent NZ-754129-A (NZ)
Title: Automated process for determining amount of meat remaining on animal carcass
Inventor: HEALEY DANIEL
IPC: G06T7/60
Filed: 2017-12-20
Abstract: An automated process assesses an amount of meat remaining on a trimmed animal carcass by generating image data of the carcass and processing the image data in a computer to calculate the amount of meat remaining on the carcass. The automated process can be carried out using an equation developed by counting pixels in an area of interest in images of a plurality of reference trimmed carcasses from which the remaining meat is thereafter scraped and weighed, to produce data points used to develop the equation which is then used to calculate the amount of meat remaining on a trimmed carcass as it proceeds down a processing line.
Patent NZ-759628-A (NZ)
Title: Light energy fluorescence excitation
Inventor: JIANG RUI
IPC: G02B21/06
Filed: 2018-11-30
Abstract: There is set forth herein a light energy exciter that can include one or more light sources. A light energy exciter can emit excitation light directed toward a detector surface that can support biological or chemical samples. The light energy exciter comprises at least one light source to emit excitation light rays; and a light pipe homogenizing the excitation light and directing the excitation light toward a distal end of the light energy exciter, the light pipe comprising a light entrance surface and a light exit surface, the light pipe receiving the excitation light rays from the at least one light source; wherein the light pipe is of tapered construction and comprises an increasing diameter, in a direction from the light entry surface of the light pipe to the light exit surface of the light pipe, throughout a length of the light pipe, the light pipe reflecting the excitation light so that light pipe exit light rays exiting the light exit surface of the light pipe define a diverging cone of light that diverges with respect to an optical axis of the light energy exciter; wherein the distal end of the light energy exciter is adapted for coupling with a detector assembly that comprises a detector surface for supporting biological or chemical samples; and wherein the light energy exciter is configured to project an illumination pattern onto the detector surface that matches a shape and size of the detector surface.
Patent NZ-761577-A (NZ)
Title: Door locks and assemblies for use in wireless guest engagement systems
Inventor: PADGETT JOHN
IPC: H04B1/3888
Filed: 2017-05-17
Abstract: A guest engagement system and associated methods provide seamless engagement with guests of facilities through the use of wireless sensing technologies. The system makes use of individual guest devices which are carried by guests and used to automatically identify and authenticate the guests throughout the facility. Services can thereby be seamlessly provided to the guests throughout the facility. The services include automatic unlocking of doors, including hotel or state room doors, based on the guests’ immediate proximity to their assigned room’s door. The services also include automated payment services provided at checkout or vending terminals, and automated log-on to interactive displays and portals, among others, based on secure wireless authentication of the guest devices.
Patent PT-105937-A (PT)
Title: Argamassa leve preparada com granulado de cortiça
Inventor: NUNES ANGELA MARIA JESUS DE SEQUEIRA SERRA
IPC: C04B18/24
Filed: 2011-10-17
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A ARGAMASSAS LEVES, CONSTITUÍDAS POR 20 A 55% DE AGREGADO CALCÁRIO OU SILICIOSO; 30 A 70% DE CIMENTO PORTLAND; 5 A 15% DE GRANULADO DE CORTIÇA; 1 A 10% DE HIDRÓXIDO DE CÁLCIO OU HIDRÓXIDO DE MAGNÉSIO; 0,05 A 1,0% DE UM DERIVADO DE CELULOSE; 0,5 A 5% DE PÓ REDISPERSÍVEL; 0,01 A 2% DE UM HIDRÓFOBO EM PÓ; 0,005 A 0,5% DE UM AGENTE INTRODUTOR DE AR; E 0 A 0,5% DE UM AGENTE INTRODUTOR DE AR E AGENTE DE CONTROLO DE TRACÇÃO. A INVENÇÃO DIZ TAMBÉM RESPEITO AO PROCESSO PARA A PREPARAÇÃO DAS REFERIDAS ARGAMASSAS, COM RECURSO A UM AGREGADO COM ORIGEM NATURAL E RENOVÁVEL. ESTAS ARGAMASSAS SÃO LEVES, PARA ALÉM DAS PROPRIEDADES DE ISOLAMENTO TÉRMICO, ISOLAMENTO ACÚSTICO, TÊM EXCELENTE DURABILIDADE, EXCELENTE COMPORTAMENTO AO FOGO COM AUSÊNCIA DE CHAMA E DE LIBERTAÇÃO DE GASES TÓXICOS.
Patent PT-108690-A (PT)
Title: Sistema e método para interface cérebro-máquina de aprendizagem de operante
Inventor: NUNO LOUREIRO
IPC: G05B13/02
Filed: 2015-07-13
Abstract: UM MÉTODO, SISTEMA E MEIOS LEGÍVEIS POR COMPUTADOR PARA UMA BMI USANDO UM DESCODIFICADOR FIXO (112) BASEADO EM RÁCIOS DE DIFERENTES BANDAS DE FREQUÊNCIA, QUE TORNAM O DESCODIFICADOR ROBUSTO, MENOS ¿NERVOSO¿, E RESISTENTE A PERTURBAÇÕES. O DESCODIFICADOR FIXO (112) PODE SER CONFIGURADO DE MANEIRA A UTILIZAR UM SUBCONJUNTO LIMITADO DE CANAIS DISPONÍVEIS. O DESCODIFICADOR PODE ASSIM SER OPTIMIZADO PARA CADA INDIVÍDUO E DEPOIS FIXADO. A SAÍDA DO DESCODIFICADOR FIXO PODE SER DISPONIBILIZADA A UM PROGRAMA DE TREINO, ASSIM PERMITINDO QUE OS INDIVÍDUOS APRENDAM RAPIDAMENTE A CONTROLAR DISPOSITIVOS, BEM COMO A CONSOLIDAR ESSE CONTROLO. O PROGRAMA DE TREINO PROPORCIONA FEEDBACK CONTÍNUO DA TRANSFORMAÇÃO A DECORRER, QUE É EMITIDO PELO DESCODIFICADOR FIXO (112) EM CONJUGAÇÃO COM O FEEDBACK DAS TRANSFORMAÇÕES QUE JÁ DECORRERAM, EM QUE O FEEDBACK EXIBE EVIDÊNCIA POSITIVA QUANDO AS METAS DA TAREFA SÃO ALCANÇADAS.
Patent PT-110683-A (PT)
Title: Dispositivo para limpeza da fenda lábio palatina
Inventor: CARLA RITA RODRIGUES MENDES
IPC: A46B9/04
Filed: 2018-04-13
Abstract: A FENDA LÁBIA PALATINA CORRESPONDE A UMA MALFORMAÇÃO ANATÓMICA CARATERIZADA POR A FORMA DE CAVIDADE ORAL SER ALTERADA POR UMA FENDA NO LÁBIO OU NO PALATO, OU MESMO ENVOLVENDO AS DUAS ESTRUTURAS. ESTA FENDA CONTRIBUI NEGATIVAMENTE PARA A ACUMULAÇÃO DE RESTOS DE COMIDA, CUJA REMOÇÃO NÃO É CONSEGUIDA DE FORMA EFICAZ COM AS ESCOVAS CONVENCIONAIS. A PRESENTE INVENÇÃO DIZ RESPEITO A UM DISPOSITIVO PARA LIMPEZA DA FENDA LÁBIO PALATINA QUE COMPREENDE: UM ADAPTADOR (1) PARA MONTAGEM NAS ESCOVAS CONVENCIONAIS (4), UM ELEMENTO FLEXÍVEL DE SUPORTE À ESCOVA (2) E UMA CABEÇA DE ESCOVA (3). ESTA CABEÇA DE ESCOVA TEM CERDAS EM TODO O PERÍMETRO E A TODO COMPRIMENTO, INCLUINDO NO TOPO, PERMITINDO ASSIM UMA LIMPEZA MAIS EFICAZ, E A COMBINAÇÃO DE MOVIMENTOS DE ROTAÇÃO E TRANSLAÇÃO. ESTE DISPOSITIVO SERÁ POTENCIALMENTE USADO POR CRIANÇAS COM FENDA LÁBIO PALATINA, COM IDADES COMPREENDIDAS ENTRE OS DOIS E OS DOZE ANOS.
Patent PT-115304-A (PT)
Title: Procedimento de login com um clique
Inventor: PETER VILLAX
IPC: G06F21/00
Filed: 2019-02-11
Abstract: UM MÉTODO E UM DISPOSITIVO SÃO APRESENTADOS PARA FAZER REGISTO DE LOGIN COM SEGURANÇA POR UM UTILIZADOR DE COMPUTADOR NUM SISTEMA DE COMPUTADOR POR MEIO DE UM IDENTIFICADOR ANÓNIMO, ELIMINANDO ASSIM O USO DE UM NOME DE UTILIZADOR E DE UMA SENHA E EXIGINDO APENAS UM CLIQUE DO UTILIZADOR PARA FAZER LOGIN NO COMPUTADOR. O IDENTIFICADOR ANÓNIMO IDENTIFICA UNICAMENTE O UTILIZADOR E PODE SER USADO COMO CHAVE CRIPTOGRÁFICA.
Patent RU-94002632-A (RU)
Inventor: CHUVASHOV V D
IPC: G01N21/43
Filed: 1994-01-26
Abstract: FIELD: refractometry. SUBSTANCE: device measuring difference of refractive indices has source of linear-polarized radiation, optical prismatic unit with three prisms and clearances between center and extreme prisms which are used as vessels for examined fluids and analyzer register. Normals of contacting faces of center prism are not located in one plane. Operation of device, that is technique of measurement of difference of refractive indices, consists in the following. Clearance between prisms are filled with examined fluids, one of them having known refractive index. Examined substances are placed one after another. Polarization plane of starting radiation on to input face of prism is situated at angle of 45 deg preferably with respect to first plane of incidence. Planes of beam incidence on substance are mutually perpendicular. Light passing through prismatic unit hits polarization analyzer-register fixing change of polarization azimuth of light which makes is possible to determine difference of refractive indices of substances. EFFECT: simplification of measurement circuit, improved authenticity of method.
Patent RU-94022659-A (RU)
Inventor: MANUJLOV A I
IPC: C09J197/02
Filed: 1994-06-10
Abstract: FIELD: chemical industry. SUBSTANCE: adhesive comprises liquid phenol- formaldehyde resin, lignosulphonate, carbamide, liquid glass, and water. The adhesive further comprises Portland cement. The claimed adhesive is superior than the prior art adhesive which uses expensive water-soluble phosphate. EFFECT: lower cost of the adhesive.